Top 10 Medical Startup Investors in Mexico in October 2023

Portfolio highlights

• Nuvocargo — Nuvocargo is your all-in-one digital platform for cross border trade between the US and Mexico. Book your shipments now
• Senzai AI — Senzai AI uses machine-learning and casual inference techniques to estimate the impact of different treatments on expected customer outcomes.
• Shinkansen — Shinkansen enables fintechs and startups to transport money automatically to consumers, suppliers, banks, and conventional networks. They free engineers, automate treasury, and reduce the cost of making transfers. Shinkansen is headquartered in Santiago, Region Metropolitana.

Portfolio highlights

• Shots Podcast Network — Shots Studios is a podcast network servicing the top podcasts on YouTube. The audio versions of the podcasts can be found on Spotify and Apple along with clips on Instagram, Snapchat and TikTok.
• DramaFever — DramaFever, a subsidiary of SoftBank Internet and Media, Inc. ("SIMI"), is the leading online destination for international television shows and movies. Our millions of young, passionate viewers discover and enjoy hit shows from around the world, with professional subtitles and HD quality across a wide variety of apps and devices. We alsopartner with AMC Networks and others to develop next-generation online entertainment sites.We're a group of 130+ people building an experience for the shows and movies our customers love watching. With roughly 50 other engineers, you'll be responsible for creating a user experience enjoyed by millions. We believe in supporting people who want to take ownership of functionality and make it the best they can. We stress communication as one of the most important parts of our job.
• Voy al Doc — Voy al Doc is Mexico’s first online medical care scheduling service, which provides online search and booking options for patients free of charge.Their service meets the needs of both patients and medical practitioners. It helps patients find a doctor of a particular specialty in the most convenient location for them and allows them to book anappointment instantly online or by phone. It also helps doctors attract and retain new patients and support them managing their appointments and filling in last minute cancellations.Voy al Doc is backed by notable VC funds in Mexico (ALL VP and Angel Ventures) and is one of the few Mexican startups that has been backed by US funds (Nala Investments). Besides from that they have received funding twice from INADEM (government support for startups).Detailed traction graphs available upon request.

Portfolio highlights

• Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
• Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
• Aglaris Ltd — Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.Aglaris produces equipment to ensure cell and tissue culture is an easy, problem-free task. By automating and controlling the cell culture processes, we can obtain cells and tissues with sufficient quality to revitalize regenerative medicine andcell therapies. The technology used by our equipment is unique and is protected by international patents.

Portfolio highlights

• Chari — Chari is an e-commerce and fintech app for traditional retailers in French-Speaking Africa allowing them to order any consumer goods they sell and get delivered for free in less than 24 hours. Chari is also a financial services provider for these retailers, offering them microloans
• Ecomm-App — Ecomm-App is an online platform that helps online merchants to manage their inventory in real-time and invoice in seconds.
• Fellow Pay — The faster, easier and fairer way to get your invoices paid and speed up your payment cycle. For B2B SMEs with long payment cycles across all industries.

Portfolio highlights

• Frizata — Frizata is the first digitally native, vertical brand in the flexitarian frozen food space.
• Capitalizarme — Capitalizarme.com is an E2E marketplace, just like Amazon or MeLi, but for real estate assets. They basically choose the best investment options and simplify the process to make a responsible investment. Discover opportunities and investment guidance, buy and manage online with just a few clicks using state-of-the-art tech.
• Katapult Commerce — Katapult Commerce eliminates the complexity and high costs of creating and operating the digital channel for supermarkets and pharmacies, integrating physical stores into the online operation with a platform that optimizes and manages everything, from online sales to ordering and delivery.

Portfolio highlights

• StrongView — Selligent is an omnichannel marketing platform for targeting marketing via data activation to provide more relevant customer experiences
• Voy al Doc — Voy al Doc is Mexico’s first online medical care scheduling service, which provides online search and booking options for patients free of charge.Their service meets the needs of both patients and medical practitioners. It helps patients find a doctor of a particular specialty in the most convenient location for them and allows them to book anappointment instantly online or by phone. It also helps doctors attract and retain new patients and support them managing their appointments and filling in last minute cancellations.Voy al Doc is backed by notable VC funds in Mexico (ALL VP and Angel Ventures) and is one of the few Mexican startups that has been backed by US funds (Nala Investments). Besides from that they have received funding twice from INADEM (government support for startups).Detailed traction graphs available upon request.
• Meru Networks — Meru Networks develops and markets wireless LAN infrastructure solutions that use virtualization to deliver pervasive, high-fidelity wireless service for business-critical voice, video and data applications. The company first introduced its award-winning virtual cell wireless architecture in 2003, and Meru products embody a complete departure fromtypical hub-based WLAN approaches, offering a wireless solution with levels of performance, reliability, security and cost-effectiveness previously found only in wired networking environments.

Portfolio highlights

• Quside — Our QRNGs let innovators build advanced solutions for cybersecurity and computation.
• wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
• Deep Detection — Multispectral x-ray camera for food & beverage inspection

Portfolio highlights

• Talently — Talently offers an intensive program that helps software developers get a better job in the technology industry, anywhere in the world. It is the accelerator of the careers of Latin American tech talent.
• Carryt — Carryt performs efficient last mile deliveries by empowering gig economy drivers with our route optimization technology and impact strategy.
• Syncfy — LATAM's leading financial API.

Portfolio highlights

• Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.
• Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
• Cella Medical Solutions — Cella Medical Solutions allows surgeons to analyze and simulate complex surgery using the latest technologies, dramatically improving results.

Portfolio highlights

• Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.